Experts unite to make cancer trial results easier to compare

NCT ID NCT03676010

Ongoing Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study brings together cancer experts to agree on standard definitions for key measurements used in cancer clinical trials, such as how long patients live without their cancer getting worse. Currently, different trials define these measurements in different ways, making it hard to compare results. The goal is to create clear guidelines that all future cancer trials can follow, helping researchers and doctors better understand which treatments work best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer cancer colon carcinoma gastrointestinal stromal tumor malignant pancreatic neoplasm neoplasm non-small cell lung carcinoma renal cell carcinoma sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Centre Georges François Leclerc

Dijon, France
Institut Bergonié

Bordeaux, 33076, France
Institut du Cancer de Montpellier

Montpellier, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.